| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
118,790,000 |
| Market
Cap: |
42.71(M) |
| Last
Volume: |
19,275,386 |
Avg
Vol: |
8,983,226 |
| 52
Week Range: |
$0.3595 - $0.3595 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
| |
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
| |
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Novavax is a biotechnology company that promotes improved global health through the discovery, development and commercialization of vaccines to prevent serious infectious diseases. Co.'s vaccine candidates, including both its coronavirus vaccine candidate, NVX-CoV2373, and its primary influenza vaccine candidate, NanoFlu, are genetically engineered, three-dimensional nanostructures of recombinant proteins critical to disease pathogenesis. NVX-CoV2373 and NanoFlu include the use of Co.'s proprietary Matrix-M™ adjuvant.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
6,000 |
| Total Buy Value |
$0 |
$0 |
$0 |
$43,042 |
| Total People Bought |
0 |
0 |
0 |
1 |
| Total Buy Transactions |
0 |
0 |
0 |
3 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-01-28 |
2023-10-27 |
2023-04-28 |
2022-04-28 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Glenn Gregory M |
SVP, Research and Development |
• – – |
2015-03-12 |
4 |
GD |
$0.00 |
$0 |
D/D |
600 |
266 |
|
- |
|
| Mcmanus Michael A Jr |
Director |
– • – |
2015-02-20 |
4 |
OE |
$1.48 |
$96,600 |
D/D |
45,000 |
122,590 |
|
- |
|
| Trizzino John |
SVP, Commercial Operations |
• – – |
2015-01-31 |
4 |
B |
$3.63 |
$23,998 |
D/D |
6,611 |
28,611 |
2.74 |
- |
|
| Phillips Barclay A |
SVP, Chief Financial Officer |
• – – |
2015-01-31 |
4 |
B |
$2.28 |
$19,125 |
D/D |
8,388 |
37,044 |
2.74 |
- |
|
| Erck Stanley C |
CEO and President |
• • – |
2015-01-31 |
4 |
B |
$2.28 |
$13,958 |
D/D |
6,122 |
97,778 |
2.81 |
- |
|
| Wilson Russell P |
SVP, Business Development |
• – – |
2015-01-31 |
4 |
B |
$2.28 |
$11,514 |
D/D |
5,050 |
64,939 |
2.74 |
- |
|
| Glenn Gregory M |
SVP, Research and Development |
• – – |
2015-01-31 |
4 |
B |
$2.28 |
$1,974 |
D/D |
866 |
866 |
2.66 |
- |
|
| Hahn Timothy Jon |
SVP, Manufacturing |
• – – |
2015-01-31 |
4 |
B |
$2.28 |
$21,270 |
D/D |
9,329 |
110,485 |
2.74 |
- |
|
| Herrmann John A Iii |
SVP, General Counsel |
• – – |
2015-01-31 |
4 |
B |
$2.28 |
$22,501 |
D/D |
9,869 |
26,483 |
2.74 |
- |
|
| Evans Gray C |
Director |
– • – |
2014-12-16 |
4 |
S |
$5.72 |
$266,915 |
D/D |
(46,701) |
313,979 |
|
- |
|
| Evans Gray C |
Director |
– • – |
2014-12-16 |
4 |
OE |
$1.03 |
$264,250 |
D/D |
250,000 |
360,680 |
|
- |
|
| Evans Gray C |
Director |
– • – |
2014-12-12 |
4 |
S |
$5.77 |
$172,962 |
D/D |
(30,000) |
110,680 |
|
- |
|
| Modi Rajiv I. |
Director |
– • – |
2014-11-20 |
4 |
S |
$5.02 |
$2,604,823 |
I/I |
(518,889) |
7,500,000 |
|
- |
|
| Modi Rajiv I. |
Director |
– • – |
2014-11-18 |
4 |
S |
$5.01 |
$472,668 |
I/I |
(94,345) |
8,018,889 |
|
- |
|
| Modi Rajiv I. |
Director |
– • – |
2014-11-17 |
4 |
S |
$5.00 |
$6,933,830 |
I/I |
(1,386,766) |
8,113,234 |
|
- |
|
| Phillips Barclay A |
SVP, Chief Financial Officer |
• – – |
2014-10-03 |
4 |
B |
$4.11 |
$20,550 |
D/D |
5,000 |
28,656 |
2.74 |
- |
|
| Hahn Timothy Jon |
SVP, Manufacturing |
• – – |
2014-10-03 |
4 |
B |
$4.05 |
$10,125 |
D/D |
2,500 |
101,156 |
2.74 |
- |
|
| Glenn Gregory M |
SVP, Research and Development |
• – – |
2014-09-26 |
4 |
S |
$4.16 |
$69,929 |
D/D |
(16,809) |
0 |
|
- |
|
| Hahn Timothy Jon |
SVP, Manufacturing |
• – – |
2014-09-25 |
4 |
B |
$4.17 |
$37,530 |
D/D |
9,000 |
98,656 |
2.74 |
- |
|
| Glenn Gregory M |
SVP, Research and Development |
• – – |
2014-07-31 |
4 |
B |
$2.28 |
$28,972 |
D/D |
12,707 |
16,809 |
2.74 |
- |
|
| Herrmann John A Iii |
SVP, General Counsel |
• – – |
2014-07-31 |
4 |
B |
$2.28 |
$20,406 |
D/D |
8,950 |
16,614 |
2.74 |
- |
|
| Hahn Timothy Jon |
SVP, Manufacturing & PD |
• – – |
2014-07-31 |
4 |
B |
$2.28 |
$21,067 |
D/D |
9,240 |
89,656 |
2.74 |
- |
|
| Phillips Barclay A |
SVP, Chief Financial Officer |
• – – |
2014-07-31 |
4 |
B |
$2.28 |
$20,037 |
D/D |
8,788 |
23,656 |
2.74 |
- |
|
| Wilson Russell P |
SVP, Business Development |
• – – |
2014-07-31 |
4 |
B |
$2.28 |
$11,375 |
D/D |
4,989 |
59,889 |
2.74 |
- |
|
| Erck Stanley C |
CEO and President |
• • – |
2014-07-31 |
4 |
B |
$2.28 |
$15,477 |
D/D |
6,788 |
91,656 |
2.81 |
- |
|
161 Records found
|
|
Page 1 of 7 |
|
|
